Trial intelligence / Profile preview

Nemonoxacin for Adult Community-Acquired Pneumonia (Phase IV, China)

CTR20181341Phase 4Completed

Sponsor
Zhejiang Medicine Co., Ltd.
Start
Oct 2018
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 4 trial of nemonoxacin in community-acquired pneumonia (CAP), sponsored by Zhejiang Medicine Co., Ltd.. Started Oct 2018; status: completed.

02

Drugs

nemonoxacin
03

Conditions

community-acquired pneumonia (CAP)

Beyond the preview

Go deeper on CTR20181341.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20181341.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call